Class IITerminatedD-0850-2020
Drug recall · February 26, 2020
Glycopyrrolate Tabs recall
Why: Failed Impurities/Degradation Specification: High Out of Specification Results for Individual Unknown Impurity.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Glycopyrrolate Tabs, USP, 1 mg, 30-count unit dose blister card, FOR INSTITUTIONAL USE ONLY, Rx Only, Packaged by Vangard, Glasgow, KY 42141; NDC 0615-8170-39.
- Lots / codes
Lot #: 8170-9004, Exp 01/2020
- Quantity
- 6929 blister cards
- Company
- NCS Healthcare of Kentucky Inc, Glasgow, KY
- Distribution
- Nationwide in the USA.
- Initiated
- January 28, 2020 · Voluntary: Firm initiated
- Classified
- February 18, 2020
- Reported
- February 26, 2020
- Ended
- February 19, 2021
- How notified
- Letter
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.